KRYXANA (Ribociclib 200 mg) is a registered trademark of Novartis Pharma.

General Warning: Regular use of Ribociclib causes disturbance in QT prolongation. This QT prolongation causes cardiovascular problems. Intake of Ribociclib can cause fetal damage.

Uses of Kryxana (Ribociclib) 200 mg Tablet

• Treatment of perimenopausal or postmenopausal women having breast cancer.
• This medication is combined with fulvestrant to treat postmenopausal women having breast cancer.

Dosage: The Ribociclib is present in a tablet form of a concentration of 200mg. The recommended starting dose of Ribociclib is 600 mg taken for 21 days with or without food followed by 7 days off treatment.Ribociclib Side Effects:

Some common side effect of Ribociclib are:

• Nausea
• Vomiting
• Diarrhea
• Hair loss
• Low blood count
• Elevation in liver enzymes
• Fatigue

Severe adverse reactions of this medication are:

• QT prolongation
• Faintness
• Tiredness
• Irregular heartbeat